Jing Dong1, Puya Gharahkhani2, Wong-Ho Chow3, Marilie D Gammon4, Geoffrey Liu5, Carlos Caldas6, Anna H Wu7, Weimin Ye8, Lynn Onstad9, Lesley A Anderson10, Leslie Bernstein11, Paul D Pharoah12, Harvey A Risch13, Douglas A Corley14, Rebecca C Fitzgerald15, Prasad G Iyer16, Brian J Reid9, Jesper Lagergren17, Nicholas J Shaheen18, Thomas L Vaughan9, Stuart MacGregor2, Sharon Love19, Claire Palles20, Ian Tomlinson20, Ines Gockel21, Andrea May22, Christian Gerges23, Mario Anders24, Anne C Böhmer25, Jessica Becker26, Nicole Kreuser21, Rene Thieme21, Tania Noder27, Marino Venerito28, Lothar Veits29, Thomas Schmidt30, Claudia Schmidt31, Jakob R Izbicki32, Arnulf H Hölscher31, Hauke Lang33, Dietmar Lorenz34, Brigitte Schumacher35, Rupert Mayershofer36, Yogesh Vashist37, Katja Ott38, Michael Vieth29, Josef Weismüller39, Markus M Nöthen25, Susanne Moebus40, Michael Knapp41, Wilbert H M Peters42, Horst Neuhaus43, Thomas Rösch23, Christian Ell22, Janusz Jankowski44, Johannes Schumacher25, Rachel E Neale45, David C Whiteman46, Aaron P Thrift47. 1. Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas. 2. Statistical Genetics, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. 3. Department of Epidemiology, MD Anderson Cancer Center, Houston, Texas. 4. Department of Epidemiology, University of North Carolina, Chapel Hill, North Carolina. 5. Pharmacogenomic Epidemiology, Ontario Cancer Institute, Toronto, Ontario, Canada. 6. Cancer Research UK, Cambridge Institute, Cambridge, United Kingdom. 7. Department of Preventive Medicine, University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California. 8. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. 9. Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington. 10. Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland. 11. Department of Population Sciences, Beckman Research Institute and City of Hope Comprehensive Cancer Center, Duarte, California. 12. Department of Oncology, University of Cambridge, Cambridge, United Kingdom; Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom. 13. Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut. 14. Division of Research, Kaiser Permanente Northern California, Oakland, California; San Francisco Medical Center, Kaiser Permanente Northern California, San Francisco, California. 15. Medical Research Council Cancer Unit, Hutchison-Medical Research Council Research Centre, University of Cambridge, Cambridge, United Kingdom. 16. Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota. 17. Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden; School of Cancer and Pharmaceutical Sciences, King's College London, London, United Kingdom. 18. Division of Gastroenterology and Hepatology, School of Medicine, University of North Carolina, Chapel Hill, North Carolina. 19. Oxford Clinical Trials Research Unit, Centre for Statistics in Medicine, Oxford, United Kingdom. 20. Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, United Kingdom. 21. Department of Visceral, Transplant, Thoracic and Vascular Surgery, University Hospital of Leipzig, Leipzig, Germany. 22. Department of Medicine II, Sana Klinikum, Offenbach, Germany. 23. Department of Internal Medicine II, Evangelisches Krankenhaus, Düsseldorf, Germany. 24. Department of Interdisciplinary Endoscopy, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Department of Gastroenterology and Interdisciplinary Endoscopy, Vivantes Wenckebach-Klinikum, Berlin, Germany. 25. Institute of Human Genetics, University of Bonn, Bonn, Germany; Department of Genomics, Life and Brain Center, University of Bonn, Bonn, Germany. 26. Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Hospital, Magdeburg, Germany; Institute of Pathology, Klinikum Bayreuth, Bayreuth, Germany. 27. Department of Interdisciplinary Endoscopy, University Hospital Hamburg-Eppendorf, Hamburg, Germany. 28. Department of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University Hospital, Magdeburg, Germany. 29. Institute of Pathology, Klinikum Bayreuth, Bayreuth, Germany. 30. Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany. 31. Department of General, Visceral and Cancer Surgery, University of Cologne, Cologne, Germany. 32. Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, University of Hamburg, Hamburg, Germany. 33. Department of General, Visceral and Transplant Surgery, University Medical Center, University of Mainz, Mainz, Germany. 34. Department of General, Visceral and Thoracic Surgery, Klinikum Darmstadt, Darmstadt, Germany. 35. Department of Internal Medicine and Gastroenterology, Elisabeth Hospital, Essen, Germany. 36. Gastroenterologie am Burgweiher, Bonn, Germany. 37. Department of General, Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, University of Hamburg, Hamburg, Germany; Kantonsspital Aarau, Aarau, Switzerland. 38. Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Heidelberg, Germany; Department of General, Visceral and Thorax Surgery, RoMed Klinikum Rosenheim, Rosenheim, Germany. 39. Gastroenterologische Gemeinschaftspraxis, Koblenz, Germany. 40. Centre of Urban Epidemiology, Institute of Medical Informatics, Biometry and Epidemiology, University of Essen, Essen, Germany. 41. Institute for Medical Biometry, Informatics, and Epidemiology, University of Bonn, Bonn, Germany. 42. Department of Gastroenterology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands. 43. Institute of Human Genetics, University of Bonn, Bonn, Germany. 44. Royal College of Surgeons in Ireland, Dublin, Ireland. 45. Cancer Aetiology and Prevention, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. 46. Cancer Control, QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia. 47. Dan L Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, Texas; Section of Epidemiology and Population Sciences, Department of Medicine, Baylor College of Medicine, Houston, Texas. Electronic address: aaron.thrift@bcm.edu.
Abstract
BACKGROUND & AIMS: Epidemiology studies of circulating concentrations of 25 hydroxy vitamin D (25(OH)D) and risk of esophageal adenocarcinoma (EAC) have produced conflicting results. We conducted a Mendelian randomization study to determine the associations between circulating concentrations of 25(OH)D and risks of EAC and its precursor, Barrett's esophagus (BE). METHODS: We conducted a Mendelian randomization study using a 2-sample (summary data) approach. Six single-nucleotide polymorphisms (SNPs; rs3755967, rs10741657, rs12785878, rs10745742, rs8018720, and rs17216707) associated with circulating concentrations of 25(OH)D were used as instrumental variables. We collected data from 6167 patients with BE, 4112 patients with EAC, and 17,159 individuals without BE or EAC (controls) participating in the Barrett's and Esophageal Adenocarcinoma Consortium, as well as studies from Bonn, Germany, and Cambridge and Oxford, United Kingdom. Analyses were performed separately for BE and EAC. RESULTS: Overall, we found no evidence for an association between genetically estimated 25(OH)D concentration and risk of BE or EAC. The odds ratio per 20 nmol/L increase in genetically estimated 25(OH)D concentration for BE risk estimated by combining the individual SNP association using inverse variance weighting was 1.21 (95% CI, 0.77-1.92; P = .41). The odds ratio for EAC risk, estimated by combining the individual SNP association using inverse variance weighting, was 0.68 (95% CI, 0.39-1.19; P = .18). CONCLUSIONS: In a Mendelian randomization study, we found that low genetically estimated 25(OH)D concentrations were not associated with risk of BE or EAC.
BACKGROUND & AIMS: Epidemiology studies of circulating concentrations of 25 hydroxy vitamin D (25(OH)D) and risk of esophageal adenocarcinoma (EAC) have produced conflicting results. We conducted a Mendelian randomization study to determine the associations between circulating concentrations of 25(OH)D and risks of EAC and its precursor, Barrett's esophagus (BE). METHODS: We conducted a Mendelian randomization study using a 2-sample (summary data) approach. Six single-nucleotide polymorphisms (SNPs; rs3755967, rs10741657, rs12785878, rs10745742, rs8018720, and rs17216707) associated with circulating concentrations of 25(OH)D were used as instrumental variables. We collected data from 6167 patients with BE, 4112 patients with EAC, and 17,159 individuals without BE or EAC (controls) participating in the Barrett's and Esophageal Adenocarcinoma Consortium, as well as studies from Bonn, Germany, and Cambridge and Oxford, United Kingdom. Analyses were performed separately for BE and EAC. RESULTS: Overall, we found no evidence for an association between genetically estimated 25(OH)D concentration and risk of BE or EAC. The odds ratio per 20 nmol/L increase in genetically estimated 25(OH)D concentration for BE risk estimated by combining the individual SNP association using inverse variance weighting was 1.21 (95% CI, 0.77-1.92; P = .41). The odds ratio for EAC risk, estimated by combining the individual SNP association using inverse variance weighting, was 0.68 (95% CI, 0.39-1.19; P = .18). CONCLUSIONS: In a Mendelian randomization study, we found that low genetically estimated 25(OH)D concentrations were not associated with risk of BE or EAC.
Authors: Axel Schmermund; Stefan Möhlenkamp; Andreas Stang; Dietrich Grönemeyer; Rainer Seibel; Herbert Hirche; Klaus Mann; Winfried Siffert; Karl Lauterbach; Johannes Siegrist; Karl-Heinz Jöckel; Raimund Erbel Journal: Am Heart J Date: 2002-08 Impact factor: 4.749
Authors: Michael B Cook; Farin Kamangar; David C Whiteman; Neal D Freedman; Marilie D Gammon; Leslie Bernstein; Linda M Brown; Harvey A Risch; Weimin Ye; Linda Sharp; Nirmala Pandeya; Penelope M Webb; Anna H Wu; Mary H Ward; Carol Giffen; Alan G Casson; Christian C Abnet; Liam J Murray; Douglas A Corley; Olof Nyrén; Thomas L Vaughan; Wong-Ho Chow Journal: J Natl Cancer Inst Date: 2010-08-17 Impact factor: 13.506
Authors: Christian C Abnet; Yu Chen; Wong-Ho Chow; Yu-Tang Gao; Kathy J Helzlsouer; Loïc Le Marchand; Marjorie L McCullough; James M Shikany; Jarmo Virtamo; Stephanie J Weinstein; Yong-Bing Xiang; Kai Yu; Wei Zheng; Demetrius Albanes; Alan A Arslan; David S Campbell; Peter T Campbell; Richard B Hayes; Ronald L Horst; Laurence N Kolonel; Abraham M Y Nomura; Mark P Purdue; Kirk Snyder; Xiao-Ou Shu Journal: Am J Epidemiol Date: 2010-06-18 Impact factor: 4.897
Authors: Debbie A Lawlor; Roger M Harbord; Jonathan A C Sterne; Nic Timpson; George Davey Smith Journal: Stat Med Date: 2008-04-15 Impact factor: 2.373
Authors: Daniela Mariosa; Robert Carreras-Torres; Richard M Martin; Mattias Johansson; Paul Brennan Journal: Int J Epidemiol Date: 2019-06-01 Impact factor: 7.196
Authors: Jue-Sheng Ong; Suzanne C Dixon-Suen; Xikun Han; Jiyuan An; Upekha Liyanage; Jean-Cluade Dusingize; Johannes Schumacher; Ines Gockel; Anne Böhmer; Janusz Jankowski; Claire Palles; Tracy O'Mara; Amanda Spurdle; Matthew H Law; Mark M Iles; Paul Pharoah; Andrew Berchuck; Wei Zheng; Aaron P Thrift; Catherine Olsen; Rachel E Neale; Puya Gharahkhani; Penelope M Webb; Stuart MacGregor Journal: Nat Commun Date: 2021-01-11 Impact factor: 14.919